At a glance
ClinicalIndex Comparison RecordPhase 2Recruiting· 100 target
Drug / intervention
Injection of drug-eluting microspheres with multiple drugs into solid tumorsdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Intra-tumor Injection of Drug-eluting Microspheres Loading With Chemodrug Plus Checkpoint Inhibitors and/or IL2 for Treatment of Advanced Solid Tumors
Second Affiliated Hospital of Guangzhou Medical University·interventional·Posted Feb 25, 2021·Updated Aug 21, 2024
In Brief
A Phase 2 clinical trial evaluating Injection of drug-eluting microspheres with multiple drugs into solid tumors for Hepatocellular Carcinoma and Solid Tumor, Adult. Currently recruiting, targeting 100 participants across 1 site.
Detailed Summary
To study the safety and clinical effect of injection of drug-eluting microspheres with multiple chemodrug and/or protein drugs into advanced solid tumors.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHepatocellular Carcinoma, Solid Tumor, Adult
CountriesChina
Collaborators--
Timeline
Phase 2Recruiting
2021202220232024202520262027202820292030203120322033203420352036
Enrollment StartNov 2020
First PostedFeb 2021
TodayJul 2026
Primary CompletionNov 2029
Study CompletionNov 2035
First PostedFeb 25, 2021
Enrollment StartNov 1, 2020
Primary CompletionNov 1, 2029
Study CompletionNov 1, 2035
TodayJul 1, 2026
Enrollment to primary: 9 yearsPosted 5.4 years agoPrimary completion in 3.3 years
Interventions
Injection of drug-eluting microspheres with multiple drugs into solid tumorsdrug
Under the guidance of CT, puncture fine needle was used to inject drug-eluting microspheres loading with multiple drugs into the tumor